Efficacy and Safety of F-18 FPCIT PET in Parkinson's Disease and Essential Tremor Patients

Summary

The purpose of this study is to determine whether F-18 FPCIT is effective and safe radiopharmaceutical for the objective diagnosis of Parkinson's disease.

Timeline

Start

2006-11

Primary completion

2007-09

Completion

2007-10

Publications

• Background Kazumata K, Dhawan V, Chaly T, Antonini A, Margouleff C, Belakhlef A, Neumeyer J, Eidelberg D. Dopamine transporter imaging with fluorine-18-FPCIT and PET. J Nucl Med. 1998 Sep;39(9):1521-30.

Drugs

Indications